Dupont Pharmaceuticals
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dupont Pharmaceuticals.The latest application filed is for "succinoylamino benzodiazepines as inhibitors of abeta protein production".
- Dupont Pharmaceuticals - Wilmington DE 19805
| Patent | Date |
|---|---|
| Succinoylamino benzodiazepines as inhibitors of Abeta protein production App 20060122169 - Olson; Richard E. | 2006-06-08 |
| Succinoylaminobenzodiazepines as inhibitors of Abeta protein production App 20060025407 - Olson; Richard E. | 2006-02-02 |
| Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives Grant 6,124,300 - Rajagopalan , et al. September 26, 2 | 2000-09-26 |
| Carbocyclic heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents Grant 6,110,910 - Magolda , et al. August 29, 2 | 2000-08-29 |
| Arylamino fused pyrimidines Grant 6,107,300 - Bakthavatchalam , et al. August 22, 2 | 2000-08-22 |
| 6-membered aromatics as factor Xa inhibitors Grant 6,060,491 - Pruitt , et al. May 9, 2 | 2000-05-09 |
| Azolo triazines and pyrimidines Grant 6,060,478 - Gilligan , et al. May 9, 2 | 2000-05-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 